X4 Pharmaceuticals, Inc. is a biopharmaceutical firm committed to the discovery, development, and commercialization of innovative therapies for uncommon immune system disorders.
52W Range
61stpctl
Volume
0.55×avg
Market Cap
381.05MUSD
P/E Ratio
-3.4TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
X4 Pharmaceuticals, Inc.
XFORNASDAQ Capital Market·USD·Closed
X4 Pharmaceuticals, Inc.
XFORNASDAQ·USD·Closed
$4.04
−4.49%
$4.04
−$0.19 (4.49%)
52W Range
61stpctl
Volume
0.55×avg
Mkt Cap
381.05MUSD
P/E
-3.4TTM
Div Yield
–ann
XFOR: X4 Pharmaceuticals, Inc. Stock Analysis | finqOS
